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 Abstract 
Regions along the Mediterranean and Southern Asia have lower prostate cancer incidence 
compared to the rest of the world. It has been hypothesized that one of the potential contributing 
factors for this low incidence includes a higher intake of vitamin E (tocopherols and 
tocotrienols). This study examines the potential of gamma tocopherol (GT) and gamma 
tocotrienol (GT3) to reduce prostate cancer proliferation by examining their effects on the NF B 
pathway. NF B is known to inhibit apoptosis in cancer cells. Our data shows that both GT and 
GT3 are capable of down regulation of NF B precursors and up regulation of Caspase 8, 
indicating an induction of apoptosis. 
 
 
 
 
 
 
 
 
 
Background 
Prostate cancer is the second leading cause of cancer deaths in and the most common 
non-cutaneous malignancy in U.S. men (1, 2). Prostate cancer growth and progression is initially 
dependent on male hormones (androgens), and is thus frequently treated using chemical and/or 
surgical androgen ablation therapy. This treatment works for a time, but in most cases the cancer 
recurs in an untreatable, androgen-independent form (2).  
The occurrence of prostate cancer varies greatly from country to country. It is far more 
frequent in North America, particularly the United States, and Western Europe than the 
Mediterranean or Asia.  Interestingly, men who relocate from countries with a low incidence of 
prostate cancer to countries with a high incidence often develop prostate cancer at a rate 
intermediate of that of their native population and their new home. This implicates diet and 
nutrition as significant factors in the development and progression of prostate cancer, and dietary 
fat has been repeatedly linked to an increase in prostate cancer risk (1). 
As a dietary antioxidant, vitamin E can bind free radicals and may help to prevent 
oxidative damage to prostate epithelium. Vitamin E naturally occurs as four tocopherol isoforms, 
alpha tocopherol (AT), beta tocopherol (BT), delta tocopherol (DT), and gamma tocopherol (GT) 
as well as four tocotrienol isoforms, alpha tocotrienol (AT3), beta tocotrienol (BT3), delta 
tocotrienol (DT3), and gamma tocotrienol (GT3). These isoforms can most commonly be found 
in vegetable oils, nuts, and whole grains (3, 4). In the Mediterranean, there is not only a balance 
of tocopherols but a higher intake than in America. Similarly, a substantial amount of 
tocotrienols (mostly GT3) is found in Palm and Rice Bran Oil, which are common in the Asian 
diet where prostate cancer incidence is lowest. This indicates that vitamin E may play some role 
in the prevention of prostate cancer.  
While the chroman head group is common in both tocopherols and tocotrienols, the 
former have three chiral carbons on its phytyl tail and the latter have a farnesyl tail with three 
unsaturated bonds.  The number and position of the methyl groups determine the specific 
tocopherol (AT, BT, GT, or DT) or tocotrienol compound (AT3, BT3, GT3, or DT3) (5). 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Vitamin E isomers (5) 
  Vitamin E’s role in cancer prevention has become something of a controversial topic in 
recent years. The results of the widely publicized SELECT trial indicated that vitamin E has no 
preventative value in prostate cancer. It is important to note, however, that the select trial used 
only AT, completely ignoring the seven other vitamin E forms. Furthermore, an exceedingly 
high dosage (400 IU daily) was provided to participants (6). Conversely the Alpha-Tocopherol, 
Beta-Carotene study (ATBC) showed a significantly decreased incidence of prostate cancer with 
vitamin E intake while examining a much lower dosage of 50 IU AT (7). The current 
recommendation for daily vitamin E intake in adults is only 22 IU (8). It is also noteworthy that 
alpha tocopherol is found four fold less in the North American diet compared with gamma 
tocopherol (9).  
Despite this, alpha-tocopherol has been the principal focus of the majority of studies 
examining the relationship between vitamin E and cancer. As it has become increasingly 
apparent that the different vitamin E isoforms act through different mechanisms, it is clear that 
this narrow focus on alpha tocopherol is not an adequate investigation of the vitamin’s 
chemopreventive effects. In fact, when compared in a large scale study, dietary gamma 
tocopherol intake was found to have an inverse, significant relationship to prostate cancer risk, 
while supplemental alpha tocopherol did not have an affect (10). Furthermore, a systematic 
review of studies concerning vitamin E and prostate cancer showed that lower doses (<300 IU) 
of vitamin E had a chemopreventive effect while higher doses (especially ≥ 400 IU) had harmful 
effects (11). 
The purpose of this study was to examine the effects of GT and GT3 on the NF B 
pathway in the PC-3 cell line. The PC-3 cell line was first isolated and characterized in 1978. It 
is derived from a human prostatic adenocarcinoma that metastasized to bone. It is a poorly 
differentiated, highly aggressive, and androgen-independent cell line (12). Results were obtained 
by treating PC-3 cells at various time points and concentrations of GT and GT3, then examining 
proteins of interest through Western Blot analysis. Efforts were made to obtain data for the 
effects of both GT and GT3 on all proteins, but technical difficulties and time constraints 
prevented this.  
Experimental Procedure 
Materials. The GT 99% pure was a generous donation by the Cognis Corporation, 
LaGrange, IL. The GT3 was generously donated by Carotech Corporation with a purity of 98%, 
(Kuala Lumpur, Malaysia). 
Cell Culture. The PC-3 prostate cancer cell line, CRL-1435 (derived from a bone 
metastasis of a grade IV of a human prostatic adenocarcinoma displaying epithelial morphology) 
was purchased from American Type Culture Collection (Manassas, VA). PC-3 cells were 
maintained as a monolayer culture in RPMI 1640 media (Gibco BRL, Rockville, MD) 
supplemented with 10% FBS and 50 IU penicillin/streptomycin in a humidified atmosphere of 
5% CO2 at 37º C and were subcultured at 75% confluence  
Enrichment of Vitamin E Media. Concentrations of Vitamin E (tocopherols or 
tocotrienols) were determined in ethanol using a HP-8542A diode array spectrophotometer with 
the following maximum 5 wavelengths (λmax) and molar extinction coefficients(Є): GT λmax = 
298 nm Є = 3810, GT3 λmax = 298 nm Є = 4230. Prior to treatment, the cell culture medium 
was enriched with tocopherol or tocotrienol by adding the appropriate amount of tocopherol in 
ethanol (ethanol concentrations never exceeded 50 μL ethanol per mL of media). In the vehicle-
treated cells, ethanol is added to the complete culture medium at the same concentration that is 
added to the treatments. 
Western Blot Analysis. The protein concentration of the cell lysates was determined by 
the BCA protein assay (Pierce Biotechnology, Rockford, IL). Cell lysates were separated by 
electrophoresis on a 10% SDS polyacrylamide gel in Tris HCl buffer and electro transferred onto 
Hybond-ECL nitrocellulose membrane as using a Biorad electroblotter at 100 V for 1 hour. 
Blotted membranes were blocked overnight with 5% BSA or 5% skimmed milk and incubated 
with the primary antibodies. Following primary antibody incubation the blots were probed with 
the appropriate secondary antibody conjugated with horseradish peroxidase. The signal was 
measured using Super Signal West Pico Chemiluminescent Substrate (Pierce Biotechnology, Inc, 
Rockford, IL). 
 
 
 
 
 
 
 
 
 
Results 
 
Figure 2: The NF B pathway 
 
 
 Figure 3: Activation of NFkB as a transcription factor 
 
TGFβ2 has been previously demonstrated to play a role in the cell survival of PC-3 cells, 
showing that the knock out of TGFβ2 results in down-regulation of NFκB, inhibiting 
proliferation of PC-3 cells (13). We therefore chose to examine the effects of GT3 on TGFβ2 
expression. We found that TGFβ2 is down regulated in cells treated with 20 M GT3 for 9 hours 
(Figure 2). 
 
  
Figure 4: TGF 2 is down regulated by GT3 
 
 
We next looked at NFκB itself to determine if our results would be consistent with the 
previous indications that TGFβ2 is involved in up regulation of NFκB. We found that NFκB was 
down regulated in cells treated with 5 M GT3 for 24 hours (Figure 3).  
 
 
 
 
Figure 5: NFkB is down regulated by GT3 
 
As we did find that GT3 modulated NFκB, we decided to further examine its effects on 
this pathway by looking at proteins known to have an effect on NFκB phosphorylation (p38, 
MKK 3/6, and TAK1) as well as targets of NFκB’s activity as a transcription factor (XIAP and 
Caspase 8). Down regulation of p38 was found with both GT and GT3 after treatment for 6 hours 
(Figures 4 and 5). Both MKK 3/6 and TAK1 were down regulated by GT3 (Figures 6 and 7). 
XIAP was down regulated by GT at 5 M and 10 M after 3 hours of treatment and by GT3 at 5 
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M after 24 hours of treatment (Figures 8 and 9). Caspase 8 is cleaved by GT at 6 M and GT3 
at 10 nM both after 24 hours of treatment (Figure 10). 
 
 
Figure 6: GT down regulates p38 
 
 
Figure 7: GT3 down regulates p38  
 
 
 
 
 
Figure 8: MKK 3/6 is down regulated by GT3 
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Figure 9: TAK1 is down regulated by GT3 
 
 
 
 
Figure 10: XIAP is down regulated by GT3 
 
 
Figure 11: XIAP is down regulated by GT 
 
 
Figure 12: Increased cleavage of Caspase 8 following treatment with both GT and GT3 
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 Discussion 
NF B must be phosphorylated to enter the nucleus and upregulate the target genes.  We 
used an antibody to phophsorylated NF B which targets the Serine 536 phosphorylation site on 
NF B.  When we saw downregulation of this site which is specific for p38 phosphorylation, we 
surmised that p38 was involved. MKK 3/6 activates p38 through phosphorylation. MKK 3/6 is in 
turn phosphorylated by TAK1, with the overall result being activation of NF B. TGF 2 
activates TAK1 and is therefore the source of NF B activation. Our results showed down 
regulation of all of these proteins, leaving NF B in its inactive form. Thus, NF B is unable to 
act as a transcription factor. Consistent with the inhibition of NF B activation, XIAP, a target of 
NF B as a transcription factor  which is up regulated by NF B is also down regulated by both 
GT and GT3. XIAP serves as an apoptosis inhibitor, by blocking the caspase pathways. The 
cleavage of Caspase 8, therefore, is consistent with our results and demonstrates that both GT 
and GT3 induce apoptosis. The results show that the positive effects of GT and GT3 treatment 
occur at low concentrations comparable to those found in the diet. Previously determined levels 
show that circulating Vitamin E concentrations range from 3 to 20 μM in the human body (14-
16), making our treatment concentrations physiologically relevant. In conclusion, GT and GT3 
are effective inhibitors of the androgen-independent prostate cancer cells of the PC-3 cell line. 
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